SOURCE: Geneart AG

November 28, 2007 08:15 ET

GENEART is again Recognized as a European "Technology Fast 500" Company

REGENSBURG, GERMANY--(Marketwire - November 28, 2007) -

Regensburg, November 28, 2007 - The GENEART AG with its above average sales growth ranks again among the fastest growing European technology companies and was therefore decorated with the "Technology Fast 500" award. Creator and organizer of the competition is the auditing and advisory services firm Deloitte. Monday evening, the 500 winners of the prize for the fastest growing technology enterprises showcased their business in London. The competition was attended by European technology companies from business sectors including communications/networking, the Internet/media, semiconductors/equipment, computers/peripherals, the life sciences/biotechnology and software. The placements are based on the cumulative sales growth in percent for the preceding consecutive five years. The publicly traded GENEART AG as the global leader in the production of synthetic genes and synthetic biology specialist grew its sales by more than 500 percent to EUR 7.8M in this five- year period and expects a further profitable growth of net sales in 2007. Among life science companies GENEART ranks 18th in the competition. Being a German "Technology Fast 50" company, GENERT had qualified for the European "Technology Fast 500" competition.

"We are very pleased that GENEART was honored as one of the fastest growing companies in Germany and Europe for the third time running. This hallmark for strong growing companies emphasizes the GENEART success in the past years and particularly our exceptional position in European biotechnology." notes Christian Ehl, CFO of the GENEART AG.

For further inquiries, please contact:

Bernd Merkl
Josef-Engert-Str. 11
93053 Regensburg
Phone: +49-(0)941-942 76-638
Fax: +49-(0)941-942 76-711

Frank Ostermair
Better Orange IR & HV AG
Haidelweg 48
81241 Munich
Phone: +49-(0)89-88 96 906-10
Fax: +49-(0)89-88 96 906-66

Legal Information

This document may contain estimates, prognoses and opinions about company plans and objectives, products or services, future results, opinions about these results or opinions leading up to these results. All these projections into the future are subject to risk, uncertainty and unforeseeable change outside the control of the GENEART Group. Many factors may lead to actual results, which considerably deviate from the given projections for these results.


In 2000, GENEART entered the gene synthesis market and has since become the global market leader. Today, the company is one of the leading specialists in the synthetic biology field. Experts at GENEART provide key technologies for the development and production of new therapeutics and vaccines. Customers also take advantage of GENEART services to customize enzyme attributes, such as the attributes of enzymes used as detergent additives, and to construct bacteria, which produce complex biopolymers or break down polymers, such as synthetics, petroleum components, etc. Our production and service spectrum spans a wide range, from the production of synthetic genes according to DIN EN ISO 9001-2000, to the creation of gene libraries in the combinatorial biology, to the development and production of DNA-based biologically active substances. The GENEART AG in Regensburg (Germany) and the subsidiary GENEART Inc. in Toronto (Canada) employ more than 140 people. Since May 2006, GENEART is listed on the German Stock Exchange.

About Deloitte

Deloitte refers to one or more of Deloitte Touche Tohmatsu, a Swiss Verein, its member firms, and their respective subsidiaries and affiliates. Deloitte Touche Tohmatsu is an organization of member firms around the world devoted to excellence in providing professional services and advice, focused on client service through a global strategy executed locally in over 140 countries. With access to the deep intellectual capital of approximately 150,000 people worldwide, Deloitte delivers services in four professional areas - audit, tax, consulting, and financial advisory services - and serves more than 80 percent of the world's largest companies, as well as large national enterprises, public institutions, locally important clients, and successful, fast-growing global companies. Services are not provided by the Deloitte Touche Tohmatsu Verein, and, for regulatory and other reasons, certain member firms do not provide services in all four professional areas. As a Swiss Verein (association), neither Deloitte Touche Tohmatsu nor any of its member firms has any liability for each other's acts or omissions. Each of the member firms is a separate and independent legal entity operating under the names "Deloitte," "Deloitte & Touche," "Deloitte Touche Tohmatsu," or other related names.

Copyright © Hugin ASA 2007. All rights reserved.

Contact Information